A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection

NCT05017116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: RBD1016
DRUG: Placebo
DRUG: Entecavir

Sponsor

Suzhou Ribo Life Science Co. Ltd.